Proof of Usefulness Report

BillionToOne

Analysis completed on 1/15/2026

+838
Proof of Usefulness Score
Unicorn Utility

BillionToOne is a verified publicly traded unicorn (NASDAQ: BLLN) with ~$5B market cap and $250M+ annual revenue, demonstrating exceptional real-world utility in molecular diagnostics (prenatal and oncology). However, the submission itself was of low quality, containing hyperbolic claims ('everyone', 'most people') and basic errors (listing market cap as monthly revenue). The score reflects the massive verifiable success of the entity, penalized slightly for the poor quality of the specific submission.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+237
Audience Reach Impact+75
Technical Innovation+135
Evidence Of Traction+371
Market Timing Relevance+90
Functional Completeness+2
Subtotal+911
Usefulness Multiplierx0.92
Final Score+838

Project Details

Project URL
Description
We push the boundaries of molecular diagnostics through quantitative technologies.\n\nBillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules to the single-count level.
Audience Reach
everyone
Target Users
everyone
Technologies
Software Development
Traction Evidence
most people have used my product

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline